BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33632250)

  • 1. From SARS-CoV-2 hematogenous spreading to endothelial dysfunction: clinical-histopathological study of cutaneous signs of COVID-19.
    Patrì A; Vargas M; Buonanno P; Annunziata MC; Russo D; Staibano S; Servillo G; Fabbrocini G
    Diagn Pathol; 2021 Feb; 16(1):16. PubMed ID: 33632250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Generalized Exanthematous Pustulosis (AGEP) in 12 Patients Treated for SARS-CoV-2 Positive Pneumonia.
    Pezzarossa E; Ungari M; Caresana G; Sagradi F; Cimardi L; Pan A; Testa S; Aguggini S; Varotti E; Tanzi G; Manotti L; Ferrero G; Gusolfino MD; Trombatore M;
    Am J Dermatopathol; 2021 May; 43(5):342-348. PubMed ID: 33405402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
    Colmenero I; Santonja C; Alonso-Riaño M; Noguera-Morel L; Hernández-Martín A; Andina D; Wiesner T; Rodríguez-Peralto JL; Requena L; Torrelo A
    Br J Dermatol; 2020 Oct; 183(4):729-737. PubMed ID: 32562567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Endothelial Dysfunction and Complement Deposition in COVID-19.
    Tammaro A; Adebanjo GAR; Del Nonno F; Pezzuto A; Ramirez-Estrada S; Parisella FR; Rello J; Scarabello A
    Am J Dermatopathol; 2021 Mar; 43(3):237-238. PubMed ID: 33055532
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous manifestations in patients with coronavirus disease 2019: clinical and histological findings.
    Fattori A; Cribier B; Chenard MP; Mitcov M; Mayeur S; Weingertner N
    Hum Pathol; 2021 Jan; 107():39-45. PubMed ID: 33161030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden neck swelling with rash as late manifestation of COVID-19: a case report.
    Giannitto C; Bonifacio C; Esposito S; Ammirabile A; Mercante G; De Virgilio A; Spriano G; Heffler E; Lofino L; Politi LS; Balzarini L
    BMC Infect Dis; 2021 Feb; 21(1):232. PubMed ID: 33639889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and management of a liver transplanted patient admitted with SARS-CoV-2 infection.
    De Gottardi A; Fratila C; Bertoli R; Cerny A; Magenta L; Gianella P; Majno-Hurst P; Ceschi A; Vanini G; Bernasconi E
    Clin Res Hepatol Gastroenterol; 2020 Nov; 44(6):e141-e144. PubMed ID: 32565199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of severe psoriatic erythroderma with COVID-19.
    Ghalamkarpour F; Pourani MR; Abdollahimajd F; Zargari O
    J Dermatolog Treat; 2022 Mar; 33(2):1111-1113. PubMed ID: 32691645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalized mucinosis in a patient with erythroderma.
    Fujimura T; Okuyama R; Nakagawa S; Terui T; Aiba S
    Dermatology; 2006; 212(4):366-9. PubMed ID: 16707887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated maculopapular eruption localized to head and neck: A cutaneous sign of COVID-19 infection.
    Farabi B; Atak MF
    Dermatol Ther; 2020 Nov; 33(6):e14468. PubMed ID: 33112023
    [No Abstract]   [Full Text] [Related]  

  • 14. Histopathology of persistent long COVID toe: A case report.
    Nirenberg MS; Requena L; Santonja C; Smith GT; McClain SA
    J Cutan Pathol; 2022 Sep; 49(9):791-794. PubMed ID: 35366017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science.
    Evans PC; Rainger GE; Mason JC; Guzik TJ; Osto E; Stamataki Z; Neil D; Hoefer IE; Fragiadaki M; Waltenberger J; Weber C; Bochaton-Piallat ML; Bäck M
    Cardiovasc Res; 2020 Dec; 116(14):2177-2184. PubMed ID: 32750108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late histological findings in symptomatic COVID-19 patients: A case report.
    Aiolfi A; Bruni B; Biraghi T; Montisci A; Miceli A; Baronio B; Khor D; Cirri S; Donatelli F; Clemente C; Bona D
    Medicine (Baltimore); 2020 Jul; 99(28):e21046. PubMed ID: 32664116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19.
    Askin O; Altunkalem RN; Altinisik DD; Uzuncakmak TK; Tursen U; Kutlubay Z
    Dermatol Ther; 2020 Nov; 33(6):e13896. PubMed ID: 32579756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic stroke and purpuric dermatitis as COVID-19-related complications in a peritoneal dialysis patient.
    de Lorenzo Alvarez A; Revilla Á; Corbalán T; Villar A; Espinel L; Martins J; Cubas A
    CEN Case Rep; 2021 May; 10(2):250-254. PubMed ID: 33205335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.